XML 116 R102.htm IDEA: XBRL DOCUMENT v3.8.0.1
Interim Financial Results (Unaudited) (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 03, 2018
Dec. 02, 2017
Sep. 02, 2017
Jun. 03, 2017
Mar. 04, 2017
Nov. 26, 2016
Aug. 27, 2016
May 28, 2016
Mar. 03, 2018
Mar. 04, 2017
Feb. 27, 2016
Interim Financial Results (Unaudited)                      
Revenues $ 5,394,264 $ 5,353,170 $ 5,345,011 $ 5,436,523 $ 5,903,385 $ 5,669,111 $ 5,629,559 $ 5,725,485 $ 21,528,968 $ 22,927,540 $ 20,770,237
Cost of revenues 4,124,498 4,166,447 4,183,338 4,274,580 4,554,328 4,424,260 4,387,845 4,496,400 16,748,863 17,862,833 15,778,258
Selling, general and administrative expenses 1,181,964 1,166,514 1,141,844 1,160,940 1,253,144 1,168,646 1,175,430 1,179,775 4,651,262 4,776,995 4,581,171
Lease termination and impairment charges 47,675 3,939 3,113 4,038 25,575 7,199 7,226 5,778 58,765 45,778 40,477
Goodwill impairment 261,727               261,727 0  
Interest expense 50,603 50,308 50,857 51,000 53,391 50,303 49,703 46,668 202,768 200,065 186,132
Walgreens Boots Alliance merger termination fee     (325,000)           (325,000)    
(Gain) loss on sale of assets, net (5,249) 205 (14,951) (5,877) (6,261) (225) (560) 397 (25,872) (6,649) (606)
Total costs and expenses 5,661,218 5,387,413 5,039,201 5,484,681 5,880,177 5,650,183 5,619,644 5,729,018 21,572,513 22,879,022 20,618,637
Income (loss) before income taxes (266,954) (34,243) 305,810 (48,158) 23,208 18,928 9,915 (3,533) (43,545) 48,518 151,600
Income tax expense (benefit) 216,719 (16,061) 117,450 (12,121) 48,262 (4,682) 3,879 (3,021) 305,987 44,438 49,512
Net (loss) income from continuing operations (483,673) (18,182) 188,360 (36,037) (25,054) 23,610 6,036 (512) (349,532) 4,080 102,088
Net income (loss) from discontinued operations, net of tax 1,250,745 99,213 (17,644) (39,312) 3,912 (8,600) 8,737 (4,076) 1,293,002 (27) 63,377
Net (loss) income $ 767,072 $ 81,031 $ 170,716 $ (75,349) $ (21,142) $ 15,010 $ 14,773 $ (4,588) $ 943,470 $ 4,053 $ 165,465
Basic (loss) income per share:                      
Continuing operations $ (0.46) $ (0.02) $ 0.18 $ (0.03)         $ (0.33) $ 0.00 $ 0.10
Discontinued operations 1.19 0.10 (0.02) (0.04)         1.23 0.00 0.06
Net basic income per share 0.73 0.08 0.16 (0.07)         0.90 0.00 0.16
Diluted (loss) income per share:                      
Continuing operations (0.46) (0.02) 0.18 (0.03)         (0.33) 0.00 0.10
Discontinued operations 1.19 0.10 (0.02) (0.04)         1.23 0.00 0.06
Net diluted income per share $ 0.73 $ 0.08 $ 0.16 $ (0.07)         $ 0.90 0.00 $ 0.16
Basic and diluted (loss) income per share:                      
Continuing operations         $ (0.02) $ 0.02 $ 0.01 $ 0.00   0.00  
Discontinued operations         0.00 (0.01) 0.00 0.00   0.00  
Net basic and diluted income per share         $ (0.02) $ 0.01 $ 0.01 $ 0.00   $ 0.00  
Income tax expense recorded in connection with revaluation of deferred tax assets $ 324,765               $ 324,765    
Good will impairment, net of tax                 191,000    
Facilities impairment charges 36,927       $ 21,068            
LIFO (credit) charge $ (49,220)       $ 28,987       $ (28,827) $ (3,721) $ 7,892